Capvizr
THE DEAL, AT A GLANCE

Langlai

From the announcement
01Who is involvedBacked by CDH Investments, Shenzhen Capital GroupFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedLanglai raised Series B, announced 2026-11-13From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersLanglai's Series B is recorded at $0M in Unclassified, alongside a market context of 944 other funding rounds totaling $400273M in the trailing 30 days.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Langlai · Financing Record

Explore source-linked visual explanations for Langlai. Unsupported claims are withheld while source review continues.

Record 15995 · Recorded date: 2026-11-13

What it does

Langlai: illustrative category image
Illustrative image (biotech lab), not Langlai's product · Stephane Lesbats (IFREMER, Pôle Images, Centre Bretagne - ZI / CC BY 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 15995 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime